Roelof Botha

Director Roelof Botha sold 44,050 shares for $17,534,802.65 at blended average $398.07, reducing stake 22.6% from 194,600 shares.

Roelof Botha filed 5 separate sales totaling 44,050 shares for $17,534,802.65 on 2026-06-02, executed at prices ranging from $395.48 to $399.82. His post-transaction holdings stand at 150,550 shares, a reduction of 22.6% from his pre-transaction 194,600 shares. At a blended average of $398.07, these sales occurred at the upper end of the 52-week range ($182.43–$444.72) and significantly above the current price of $380.18. Botha's cross-ticker track record shows a 100% well-timed sell rate across 19 prior open-market sales, with an average 90-day return of -24.0% after sales—and his same-ticker history at MDB is entirely consistent, with all 5 prior sells at this company showing well-timed exits (all negative 90-day returns ranging from -35.2% to -35.8%). This filing represents a material liquidation of a director's stake, executed at historically strong prices in a company that was unprofitable over its most recent full fiscal year despite 22.8% annual revenue growth.

Director Roelof Botha sold 78,000 shares at NTRA for $17.2M; 5 of 5 prior same-ticker sells were well-timed at 90-day mark.

Roelof Botha executed 6 separate sales totaling 78,000 shares for $17,184,092.05, reducing his holdings from 1,154,198 to 1,076,198 shares. His prior trade history at NTRA shows a consistent pattern: all 5 previous sales on 2025-11-24 were well-timed at the 90-day mark, with each recording negative 90-day returns ranging from -7.4% to -9.2%, indicating the stock declined after each sale. The company is unprofitable with net income of $-85,091,000.00 over its most recent full fiscal year, though revenue grew +35.9% year-over-year to $696,644,000.00. Current price of $211.85 is -17.4% from the 52-week high of $256.36, suggesting this director's historical execution pattern has aligned with subsequent price weakness.

Director Roelof Botha purchases 260,525 shares of LIFE at $19.00 on 2026-01-29; cluster pattern with 2 other insiders buying within 14 days.

Director Roelof Botha acquired 260,525 shares at $19.00 for a total value of $4,949,975.00 on 2026-01-29, just 3 trading days after Ethos Technologies Inc. (LIFE) listed. This purchase reflects participation in a cluster pattern, with 2 other insiders also buying within the past 14 days, suggesting coordinated insider accumulation early in the company's public trading history. The stock currently trades at $13.90 as of 2026-02-02, representing a decline from the transaction price. The filing reflects a conversion of derivative securities into common shares (Form 4 Table II), not a position exit; investors should examine the fuller derivative holdings context to assess the director's total economic exposure.

Director Botha sold 24,850 shares of MDB for $10,085,418.31 across 11 transactions at $405.85 blended average.

Roelof Botha executed 11 separate sales totaling 24,850 shares for $10,085,418.31 on 2025-12-05, reducing his holdings from 219,450 shares to 194,600 shares (-11.3% of pre-transaction holdings). The blended average sale price was $405.85, slightly below the current price of $414.06. At the same-ticker level, Botha's prior two sales at MDB (both on 2024-03-13) were well-timed at the 90-day mark, with the stock declining 40.2% and 40.1% respectively after those sales. His cross-ticker track record shows 18 prior sells with a 100% well-timed rate at 90 days and an average 90-day return of -17.0%, though this broader pattern does not necessarily predict outcomes at MDB specifically. The company remains unprofitable (net income of $-2.0M in the latest quarter) despite revenue growth of 19.2% annually, which forms the context for evaluating the significance of a substantial director reduction.

Director Roelof Botha sold 75,000 NTRA shares for $17.7M on 2025-11-24 as stock near 52-week high; 5 prior NTRA sells 100% well-timed against declines.

Roelof Botha executed 11 separate sales totaling 75,000 shares for $17,708,935.58 ($17.7M) on 2025-11-24, reducing his stake by 6.1% to 1,154,198 shares. The sales occurred at prices ranging from $228.97 to $238.57, with a blended average of $236.12, just 0.6% below the 52-week high of $238.58. Within 30 days, NTRA stock rose 23.4%; over 90 days it rose 41.2%—both well above his cross-ticker track record for prior sells (average 30-day return -5.8%, average 90-day return -25.3%). However, his SAME-TICKER HISTORY at NTRA is distinct and highly relevant: his 5 prior sells on 2024-12-02 achieved a 100% well-timed rate at the 90-day mark, each followed by declines ranging from -5.1% to -7.2%. This contrasts sharply with the current post-sale price action. The company remains unprofitable (net income $-87.5M) despite strong revenue growth of 56.8%, leaving the question of whether this sale reflects a shift in his timing pattern at this specific ticker or an outlier in his otherwise disciplined execution history.

Director Roelof Botha sold 87,473 shares for $14.8M at blended avg $169.12; holds 1.22M shares post-sale as stock hits 52-week high of $174.00

Director Roelof Botha executed 5 separate sales totaling 87,473 shares for $14,793,563.24 on 2024-12-02, reducing his holdings by 6.7% to 1,224,787 shares. The sales spanned a narrow price band from $166.88 to $170.54, with a blended average of $169.12, occurring as NTRA stock is currently at $174.00 (its 52-week high of $174.00) following a 41.0% 30-day and 48.1% 90-day surge. Across his cross-ticker track record, Botha's prior 6 sells showed a 100.00% well-timed rate with -40.0% average 90-day returns, though the company itself remains unprofitable (net income $-31.6M in the latest quarter) despite 32.0% annual revenue growth. The timing of this liquidation at equity peaks, combined with a market-cap business still in net-loss territory, presents a signal warranting investor scrutiny of near-term fundamentals and cash-burn trajectories.

Director Roelof Botha purchases 434.4K SQ shares in 2 transactions for $25,001,586.76 at blended avg $57.55

Roelof Botha, a director at Block, Inc., executed 2 separate open-market purchases totaling 434,405 shares for $25,001,586.76 on 2024-08-06 at prices of $56.86 and $57.82, establishing a new position. This transaction follows a striking pattern: Botha's 4 prior purchases at SQ (all in November 2023) were each well-timed, delivering positive 90-day returns ranging from +31.2% to +35.9%, with a perfect 4 of 4 timing success rate at this ticker. His broader cross-ticker track record shows 4 prior buys averaging +36.2% 30-day return and +33.0% 90-day return. The current stock price of $61.21 is down -5.1% over 30 days and -14.2% over 90 days from the purchase date, though up significantly from the transaction prices. The high P/E of 3060.50 reflects near-zero net profitability relative to market valuation, warranting scrutiny of whether fundamentals support the position.